Low dose tamsulosin for stone expulsion after extracorporeal shock wave lithotripsy: efficacy in Japanese male patients with ureteral stone

International Journal of Urology : Official Journal of the Japanese Urological Association
Masayuki KobayashiTomohiko Ichikawa

Abstract

We evaluated the efficacy of low dose tamsulosin after extracorporeal shock wave lithotripsy (ESWL) in Japanese male patients with ureteral stone. One hundred and two Japanese male patients with ureteral stones who underwent ESWL were randomly divided into three groups. Group A (38 patients) was given tamsulosin (0.2 mg/day); group B (30 patients) was given c horeito, a herbal medicine (7.5 g/day); and group C (34 patients) received no medication. Stone clearance was assessed at 1, 7, 14, and 28 days after ESWL using plain abdominal radiography and abdominal ultrasonography. After 28 days, stone delivery was checked every 2 weeks. The stone-free rate was 84.21%, 90%, and 88.24% for groups A, B, and C, respectively (P = 0.3425). The mean expulsion time was 15.66 +/- 6.14 days in group A, 27.74 +/- 25.36 days in group B, and 35.47 +/- 53.70 days in group C. The expulsion time of group A was significantly shorter than that of groups B (P = 0.0116) and C (P = 0.0424). The addition of tamsulosin to conservative treatment appeared to be effective in shortening the stone expulsion time.

References

Apr 1, 1970·British Journal of Urology·J M MalinS Boyarsky
May 1, 1995·International Journal of Urology : Official Journal of the Japanese Urological Association·T KoideK Sugiyama
Jun 23, 1998·Lancet·C Y Pak
Aug 24, 1999·The Journal of Urology·O F Miller, C J Kane
Oct 26, 1999·BJU International·H N Whitfield
Oct 6, 2000·Urology·J T CooperT P Cooper
Mar 26, 2002·The Journal of Urology·Yair LotanMargaret S Pearle
Feb 4, 2005·Neurourology and Urodynamics·Sandra SigalaGiovanni Muzzonigro
Jul 28, 2005·International Journal of Urology : Official Journal of the Japanese Urological Association·Sefa ResimAhmet Ciftci
Dec 1, 2005·Urological Research·Riccardo AutorinoMassimo D'Armiento
Jul 31, 2007·European Journal of Pharmacology·Yoshitaka TomiyamaYoshinobu Yamazaki
Aug 8, 2007·International Journal of Urology : Official Journal of the Japanese Urological Association·Yasunori ItohKenjiro Kohri
Nov 2, 2007·Urological Research·Hyoung Keun ParkByoung Kwon Kim

❮ Previous
Next ❯

Citations

Dec 21, 2010·Journal of Endourology·Siavash FalahatkarAliakbar Allahkhah
Jun 30, 2009·European Urology·Christian SeitzUlrike Zwergel
Sep 16, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Yasuo TsuzakaYukio Homma
May 12, 2010·BJU International·Timothy Y TsengPhilipp Dahm
Jan 20, 2015·International Journal of Urology : Official Journal of the Japanese Urological Association·Tomonori Minagawa, Osamu Ishizuka
Mar 6, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Tomoyuki KanekoYukio Homma
Sep 6, 2011·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Jarques LucioAntonio Carlos Lima Pompeo
Apr 4, 2013·Korean journal of urology·Hee Ju ChoTag Keun Yoo
Aug 12, 2014·World Journal of Gastroenterology : WJG·Tao TaoYan-Qing Li
Nov 13, 2020·The Cochrane Database of Systematic Reviews·Makinna C OestreichPhilipp Dahm

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.